⌘K

Login Start Free

Home/Filings/4/0001179110-21-007265

4//SEC Filing

Galle Liz 4

Accession 0001179110-21-007265

CIK 0001235912other

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:28 PM ET

Size

5.2 KB

Accession

0001179110-21-007265

Insider Transaction Report

Form 4

Period: 2021-06-29

VP of Global Clinical Research

Transactions

Award
Stock Option (right to buy)
2021-06-29+19,700→ 19,700 total
Exercise: $18.00Exp: 2031-06-28→ Common Stock (19,700 underlying)

Footnotes (1)

[F1]Vests as to 25% of the shares on June 29, 2022 and as to 1/48th of the shares each month thereafter.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

CVRx, Inc.

CIK 0001235912

Entity typeother

Related Parties

1

filerCIK 0001869353

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 5:28 PM ET
Size: 5.2 KB

View on SEC.gov